Cargando…
Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease
AIMS: The number of patients with both chronic obstructive pulmonary disease (COPD) and heart failure (HF) is increasing in Asia, and these conditions often coexist. We previously revealed a tendency of beta‐blocker underuse among patients with HF with reduced ejection fraction (HFrEF) and COPD in A...
Autores principales: | Kubota, Yoshiaki, Tay, Wan Ting, Teng, Tiew‐Hwa Katherine, Asai, Kuniya, Noda, Takashi, Kusano, Kengo, Suzuki, Atsushi, Hagiwara, Nobuhisa, Hisatake, Shinji, Ikeda, Takanori, Yasuoka, Ryobun, Kurita, Takashi, Shimizu, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497364/ https://www.ncbi.nlm.nih.gov/pubmed/34189870 http://dx.doi.org/10.1002/ehf2.13489 |
Ejemplares similares
-
Chronic obstructive pulmonary disease and β‐blocker treatment in Asian patients with heart failure
por: Kubota, Yoshiaki, et al.
Publicado: (2017) -
Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia
por: Ueda, Nobuhiko, et al.
Publicado: (2023) -
Comparison of second appropriate defibrillator therapy occurrence in patients implanted for primary prevention and secondary prevention – Sub-analysis of the Nippon Storm Study-
por: Kotake, Yasuhito, et al.
Publicado: (2020) -
Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2015) -
Efficacy and Feasibility of the Submuscular Implantation Technique for an Implantable Cardiac Electrical Device
por: Asamura, Shinichi, et al.
Publicado: (2014)